Adarza BioSystems
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
150 Lucius Gordon Dr Ste 100, West Henri...Phone Number
(636) 272-3233Website
www.adarzabio.comRevenue
$14.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Adarza BioSystems
Adarza is a leading developer and manufacturer of label-free biosensor assays and instruments servicing life science research, drug development and, in-vitro diagnostics customers. Adarza's platform is capable of rapidly identifying and quantifying a series of biological target analyte species in a fluid sample, without chemical labels or complex processing. Adarza's technology offers key performance benefits in speed, ease of use, large screening arrays, and custom assays as well as industry-standard expectations for sensitivity, sample size, and dynamic range. Adarza products address broad quantitative analyte detection applications, including cancer biomarkers, drug and vaccine development, allergy, immunology, and infectious diseases research.Explore more
Adarza BioSystems Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Adarza BioSystems your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Adarza BioSystems had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Adarza BioSystems
Website visits: Recent activity has been detected on your website
Check out if Adarza BioSystems is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Adarza BioSystems, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Adarza BioSystems launches new products
Funding: Get notified immidiatlly once Adarza BioSystems has new funding data
Check if Adarza BioSystems has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Adarza BioSystems recently announced quarterly report
Recommended Actions
Find VP level buyers at Adarza BioSystems
Find more new buyers
Compare Similar Companies to Adarza BioSystems
Compare insights from companies similar to Adarza BioSystems, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Adarza BioSystems is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Adarza BioSystems is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Adarza BioSystems.
Adarza BioSystems financials insights
Gather financial insights about Adarza BioSystems, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Angel/Seed
$250K
2014
Series A
$6M
2016
Series B
$5M
2017
Series C
$17M
2020
Series D
$25M
Debt
$350K
Adarza BioSystems Tech Stack
A closer look at the technologies used by Adarza BioSystems
Most Recent Scoops
Funding
Adarza BioSystems has received an SBA PPP loan for $350,000-1 million from Cross River Bank.
Funding
, a biotechnology company presenting a label-free analyte detection platform technology, has secured $25 million in a Series D funding round led by 3x5 Partners and Lightchain Capital.
Funding
Funding
Adarza BioSystems recently secured an undisclosed amount of capital in an unknown Series funding round.
Funding
Funding
Adarza BioSystems recently secured $17 million in a Series C funding round. RiverVest led the investment.
Funding
Funding
Funding
Adarza BioSystems News & Media
Adarza BioSystems Raises $25 Million in Series D Funding Round
The company said it will use the financing to support the commercialization of its automated biological testing platform for academic and clinical research.Adarza BioSystems Raises $25M Series D
ST. LOUIS, MO, Biotech company Adarza BioSystems announced today that it has raised $25 million in a Series D round.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Adarza BioSystems
Sign Up For FreeTo access detailed company insights
Adarza is a leading developer and manufacturer of label-free biosensor assays and instruments servicing life science research, drug development and, in-vitro diagnostics customers. Adarza's platform is capable of rapidly identifying and quantifying a series of biological target analyte species in a fluid sample, without chemical labels or complex p... Read More
